Jasmine Clark
Tracked across 5 events · 30 articles · First seen May 19, 2026 · Last active Aug 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Jasmine Clark, Co-founder, Chairwoman and CEO of InnoCare Pharma, announced the approval of orelabrutinib in Australia, highlighting its significance for the company's global footprint and patients.
May 27, 2026 · 6 articles
Tech
Impact: Jasmine Clark, Co-Founder, Chairwoman, and CEO of InnoCare Pharma, expressed satisfaction with the clinical development progress of ICP-B208, highlighting the company's innovative platform and commitment to providing better cancer treatment options.
Jul 05, 2026 · 6 articles
Regulatory
Impact: As CEO of InnoCare, Jasmine Clark is the public face of the announcement and her leadership is central to the company's strategic direction. The BTD reflects positively on her management and the company's innovation strategy.
Aug 03, 2026 · 6 articles
Domestic
Impact: Jasmine Clark>>> is a state Representative and a Democratic candidate for the 13th U.S. House District in United States — Georgia (U.S. state)>>>.
May 19, 2026 · 6 articles
Tech
Impact: Jasmine Clark, CEO of InnoCare, announced the trial results and expressed optimism about advancing the drug to regulatory filing, reflecting leadership in the company's progress.
Jul 27, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Jasmine Clark live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard